Tag: Healthcare Policy
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program A recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
Reforming FDA to Help Rare Disease Patients
President Donald Trump has the potential to revolutionize the landscape of rare disease treatments and save countless American lives through strategic policy changes, innovative science, and strong leadership within government agencies. This ambitious claim...
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks Controversy President Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has stirred a heated debate among policymakers and healthcare experts. The...
Revolutionizing Wellness: How Modern Legal Frameworks Impact Health Rights
Explore how evolving legal frameworks reshape health rights, balancing innovation and regulation to transform access to modern wellness technologies.
2024 Election: Understanding the Political Impact of Mifepristone
Hello readers of D.C. Diagnosis! Hope you all had a great Olympic season. If you have any news or tips to share, feel free to send them to our email. Let's dive into the...
Millions Uninsured as Medicaid Programs Reduce Coverage: New Data
Millions of Americans have found themselves without health insurance coverage as state Medicaid programs have reduced their coverage, leading to an increase in the national uninsured rate from 7.7% to 8.2% earlier this year,...
Biden’s Medicare Advantage Regulation Boosts Payments to Insurers
Biden's Medicare Advantage Regulation Boosts Payments to Insurers In a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...
Trump’s FDA and NIH Picks, FDA Office Crunch: Pharmalittle Update
As the week comes to a close, many of us are looking forward to some well-deserved rest and relaxation. Personally, I'm excited to spend time with loved ones, walk my furry friends, and enjoy...
Medicaid Official Criticizes Republican Reform as Poor Policy
Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and other priorities. The outgoing Medicaid chief under the Biden administration...
Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance
RFK Jr.'s Unconventional Stance on Health Insurance In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee policy. Pitts, who served as the senior official in charge...
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs In a groundbreaking move, Medicare officials have announced plans to negotiate the prices of two widely-used drugs for diabetes and weight loss. Ozempic and Wegovy,...

















